Use of echocardiography for the phenotypic assessment of genetically altered mice.
about
Targeted Sprouty1 overexpression in cardiac myocytes does not alter myocardial remodeling or functionSildenafil and cardiomyocyte-specific cGMP signaling prevent cardiomyopathic changes associated with dystrophin deficiencyTranscriptional and functional profiling of human embryonic stem cell-derived cardiomyocytesEffects of anesthesia on conventional and speckle tracking echocardiographic parameters in a mouse model of pressure overload.Micro-ultrasound for preclinical imaging.Comprehensive cardiovascular magnetic resonance of myocardial mechanics in mice using three-dimensional cine DENSE.MR in mouse models of cardiac disease.Myocardial infarct size and area at risk assessment in mice.New approaches in small animal echocardiography: imaging the sounds of silence.A new method for detection and quantification of heartbeat parameters in Drosophila, zebrafish, and embryonic mouse heartsrAAV6-microdystrophin preserves muscle function and extends lifespan in severely dystrophic mice.Affecting Rhomboid-3 function causes a dilated heart in adult Drosophila.Hypertension from targeted ablation of chromogranin A can be rescued by the human orthologACE2 improves right ventricular function in a pressure overload model.Multichannel pulsed Doppler signal processing for vascular measurements in mice.Tachycardia, reduced vagal capacity, and age-dependent ventricular dysfunction arising from diminished expression of the presynaptic choline transporter.Effect of lactation on maternal postpartum cardiac function and adiposity: a murine modelSmooth muscle LDL receptor-related protein-1 deletion induces aortic insufficiency and promotes vascular cardiomyopathy in micePoor functional recovery after transplantation of diabetic bone marrow stem cells in ischemic myocardium.Murine left atrium and left atrial appendage structure and function: echocardiographic and morphologic evaluationEarly myocardial dysfunction in streptozotocin-induced diabetic mice: a study using in vivo magnetic resonance imaging (MRI).Deficiency of beta1 integrins results in increased myocardial dysfunction after myocardial infarctionThree-Directional Evaluation of Mitral Flow in the Rat Heart by Phase-Contrast Cardiovascular Magnetic Resonance.Aging-related defects are associated with adverse cardiac remodeling in a mouse model of reperfused myocardial infarctionApplication of echocardiography on transgenic mice with cardiomyopathies.Testosterone negatively regulates right ventricular load stress responses in mice.Chronic phospholamban inhibition prevents progressive cardiac dysfunction and pathological remodeling after infarction in rats.Cardiac-specific succinate dehydrogenase deficiency in Barth syndromeIn vivo mouse imaging and spectroscopy in drug discovery.Molecular imaging of bone marrow mononuclear cell homing and engraftment in ischemic myocardiumDifferentiation, survival, and function of embryonic stem cell derived endothelial cells for ischemic heart disease.Genetic modification of embryonic stem cells with VEGF enhances cell survival and improves cardiac function.Age- and gender-related changes in ventricular performance in wild-type FVB/N mice as evaluated by conventional and vector velocity echocardiography imaging: a retrospective study.The cardiovascular physiologic actions of urocortin II: acute effects in murine heart failure.Scavenging superoxide selectively in mouse forebrain is associated with improved cardiac function and survival following myocardial infarction.CITED4 induces physiologic hypertrophy and promotes functional recovery after ischemic injury.Phenotypic assessment of pulmonary hypertension using high-resolution echocardiography is feasible in neonatal mice with experimental bronchopulmonary dysplasia and pulmonary hypertension: a step toward preventing chronic obstructive pulmonary diseaEffect of in vitro maturation of mouse oocytes on the health and lifespan of adult offspring.Echocardiographic assessment of global left ventricular function in mice.Impaired relaxation is the main manifestation in transgenic mice expressing a restrictive cardiomyopathy mutation, R193H, in cardiac TnI.
P2860
Q24630540-39839662-3013-4DFC-8745-DCF9F0F9C5E7Q24655371-CB22686E-5DD3-47BD-8D81-430A865B53E1Q27438164-140B1002-83DE-4657-B40A-ABB1E0743782Q30407804-12E4B8A3-E2FB-4C37-AC89-FF79F8080CB6Q30425612-CC913011-7331-4B9D-9189-B773F17165FAQ30428359-5E13F0BE-74D2-4D05-8303-244C8FE0A847Q30443476-034BC9C7-4E8E-4B8F-9773-9FF1B752E353Q30455433-AA5AFBE1-319C-40CE-860F-E7561C5BB204Q30461404-B39C0A43-AFA0-4408-89E7-ED3ED08C97E2Q30494115-2F04B806-01DF-4C90-B4AA-3B44A78903D2Q30602105-C93A56A5-B518-4390-9F1E-9B6A64B9B866Q33594430-DDD51F2C-F57F-4ED1-9412-11E930D6F858Q33865893-247BA1F7-75C9-432F-B420-BD3E249A57DEQ33939495-33CA01EC-9C7A-48C9-BEB1-FBD69047058FQ33978516-41CC9C0F-4983-4ADE-BFFF-6CF9DFE6717AQ34150552-8FACBFF2-9E92-4D2F-AE6F-7BE4F9097205Q34250268-23B16679-7999-43DC-8717-EC7AA2558162Q35060855-B6F3F236-C687-4EB3-9C9B-52FB83AB99E3Q35185979-DD004F02-B66B-44BE-9E11-BFB04CCD4459Q35558193-31947076-68AA-4C4F-8AE1-E832AA3E890EQ35651787-59F3FEE6-71E5-4105-B381-4A08312DAF6EQ35772306-0A72BC34-6A4F-4FEF-8CE8-A74F0026C507Q35940745-DFBB1D7A-2229-48B6-B1FE-21A22140B943Q35947836-0809BC73-AEBB-4F4B-8D1F-F399B05F48A0Q35998107-5CA29745-3F8A-45A1-945B-DEA7DBB28999Q36366090-35C18033-8E84-45A0-853D-6A3C8A1B8669Q36441343-3C53B6B1-5F1C-47B4-9926-5D7D7C85BB5BQ36525892-98B5A83D-305F-4787-814A-98F38B6C0662Q36798571-3172D93B-2254-476A-BEFA-80CA1BF98160Q36853933-5C8B9045-549D-44F5-9A44-B57412ADB123Q36853950-ABBA30CD-ADCE-4468-821D-F09767D1968AQ36853977-A22F3D91-9068-4E99-B1B6-DA2EC4EC75C1Q36872276-966C1F0C-FDE2-491D-88B5-6DB457A4FF3EQ37074843-A6FA7AAD-25B8-4FC7-88EC-AFDDC4E79868Q37086388-4D256188-42FA-46F9-A780-AE7E383BA4BCQ37095190-734783B2-82C1-4561-9A29-CC839DEBDF20Q37109084-94D0282A-7F11-4843-B463-5BF79FEC10BFQ37291562-9584518B-7112-4C7C-AD32-6E40B26BBE37Q37399761-9941A473-87CD-4183-AA19-A10B4F573F0FQ37403663-EE7252CB-0A79-4D6F-83DC-5D1BBDE0ED84
P2860
Use of echocardiography for the phenotypic assessment of genetically altered mice.
description
2003 nî lūn-bûn
@nan
2003 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Use of echocardiography for the phenotypic assessment of genetically altered mice.
@ast
Use of echocardiography for the phenotypic assessment of genetically altered mice.
@en
type
label
Use of echocardiography for the phenotypic assessment of genetically altered mice.
@ast
Use of echocardiography for the phenotypic assessment of genetically altered mice.
@en
prefLabel
Use of echocardiography for the phenotypic assessment of genetically altered mice.
@ast
Use of echocardiography for the phenotypic assessment of genetically altered mice.
@en
P2093
P2860
P1476
Use of echocardiography for the phenotypic assessment of genetically altered mice.
@en
P2093
Claudia E Korcarz
Keith A Collins
Roberto M Lang
P2860
P304
P356
10.1152/PHYSIOLGENOMICS.00005.2003
P577
2003-05-13T00:00:00Z